CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- S-1 Offering Registration Statement
- 8-K Event Bylaws or fiscal year change
- 8-K Event Shareholder rights changed · Shareholder vote results · Other events
- 4 Open-market sale Director sold 4,366 shares at $0.81 ($3,515)
- 4 Open-market sale Director sold 32,300 shares at an average $0.79 ($25,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 25 of 38 · 753 filings